{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:40:50Z","timestamp":1781134850102,"version":"3.54.1"},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T00:00:00Z","timestamp":1286323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aims\u2003<\/jats:bold> More than half of infants exposed to opioids <jats:italic>in utero<\/jats:italic> develop neonatal abstinence syndrome (NAS) of severity to require pharmacological therapy. Current treatments are associated with prolonged hospitalization. We sought to optimize the dose of sublingual buprenorphine in the treatment of NAS.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> Randomized, Phase 1, open\u2010label, active\u2010control clinical trial comparing sublingual buprenorphine to oral morphine.<\/jats:p><jats:p><jats:bold>Setting\u2003<\/jats:bold> Large, urban, tertiary care hospital.<\/jats:p><jats:p><jats:bold>Participants\u2003<\/jats:bold> Twenty\u2010four term infants requiring pharmacological treatment for NAS.<\/jats:p><jats:p><jats:bold>Measurements\u2003<\/jats:bold> Outcomes were neonatal safety, length of treatment and length of hospitalization.<\/jats:p><jats:p><jats:bold>Findings\u2003<\/jats:bold> Sublingual buprenorphine was safe and effective. Infants treated with buprenorphine had a 23\u2010day length of treatment compared to 38 days for those treated with morphine (<jats:italic>P<\/jats:italic>\u2003=\u20030.01), representing a 40% reduction. Length of hospital stay in the buprenorphine group was reduced 24%, from 42 to 32 days (<jats:italic>P<\/jats:italic>\u2003=\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusions \u2003<\/jats:bold> Sublingual buprenorphine was safe in NAS, with a substantial efficacy advantage over standard of care therapy with oral morphine.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2010.03170.x","type":"journal-article","created":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T16:13:29Z","timestamp":1286381609000},"page":"574-580","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome"],"prefix":"10.1111","volume":"106","author":[{"given":"Walter K.","family":"Kraft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Dysart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.6.1079"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0009922807300699"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.095166"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211427"},{"issue":"3","key":"e_1_2_8_6_2","first-page":"CD002059","article-title":"Opiate treatment for opiate withdrawal in newborn infants","author":"Osborn D. A.","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"e_1_2_8_7_2","first-page":"CD002053","article-title":"Sedatives for opiate withdrawal in newborn infants","author":"Osborn D. A.","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/fn.88.1.F2"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2009.0006"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.adnc.2005.06.003"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.07.001"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.123099"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.02073.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-007-9176-1"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.088"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2001.00657.x"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0571"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"e_1_2_8_19_2","first-page":"1367","volume-title":"Primary Pediatric Care","author":"Finnegan L. P.","year":"1992"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.152769"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000047157"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.033555"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1561"},{"key":"e_1_2_8_24_2","first-page":"232","article-title":"Neonatal abstinence syndrome","volume":"92","author":"Coghlan D.","year":"1999","journal-title":"Ir Med J"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/000992289002900208"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPM.2007.063"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0978"},{"key":"e_1_2_8_28_2","first-page":"308","article-title":"Drug withdrawal in newborns\u2014clinical data of 49 infants with intrauterine drug exposure: what should be done?","volume":"220","author":"Blaser A.","year":"2008","journal-title":"Klin Padiatr"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2010.03170.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2010.03170.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T20:06:43Z","timestamp":1697573203000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2010.03170.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1111\/j.1360-0443.2010.03170.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03170.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,6]]},"assertion":[{"value":"2010-10-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}